Cardiac dimensions, intraventricular septum thickness in relation to the estimated glucose disposal rate individuals with long-standing type 1 diabetes: a cross-sectional analysis of the PARADISE T1DM study

Authors

DOI:

https://doi.org/10.20883/medical.e1124

Keywords:

type 1 diabetes, echocardiography, insulin resistance, left ventricle

Abstract

Aim. Insulin can stimulate the growth of various cells, including cardiomyocytes, through the insulin-like growth factor (IGF) signaling pathway. Insulin resistance (IR), characterized by elevated circulating insulin levels, complicates long-standing type 1 diabetes mellitus (T1DM). This study investigates whether IR in T1DM is associated with cardiac remodeling.

Material and methods. IR was assessed using the estimated glucose disposal rate (eGDR) in 84 adults with T1DM of at least 5 years. Participants with an eGDR at or below the median value were considered more insulin resistant. Transthoracic echocardiography was used to measure left ventricular end-diastolic diameter (LVEDD), intraventricular septal thickness (IVST), right ventricular end-diastolic diameter (RVEDD), and left atrial diameter (LAD). Participants were divided into two groups based on the median eGDR value. Comparisons between groups were made using the Mann-Whitney test.

Results. The median age of the participants was 40.5 years (range: 34.0-51.0), with a T1DM duration of 21.0 years (range: 15.5-27.0) and eGDR of 7.4 (range: 5.1-9.5). Of the participants, 52 (61.9%) were men. Individuals with lower eGDR had larger cardiac diameters (all in cm): LVEDD (4.5 [4.3-4.8] vs 4.75 [4.5-5]; p=0.01), LVEDD(2.7 [2.5-2.8] vs 2.8 [2.6-2.9]; p=0.02), end-systolic LAD (3.5 [3.2-3.7] vs 3.8 [3.5-3.9]; p<0.01), and thicker IVS (0.9 [0.8-1] vs 1.1 [1-1.18]; p<0.01).

Conclusions. Individuals with T1DM and lower eGDR values exhibited more pronounced cardiac remodeling, with greater LVEDD, RVEDD, and LAD dilation and increased IVST. These findings suggest that people with T1DM at risk of IR have more commonly adverse cardiac structural changes, though causality remains uncertain.

Downloads

Download data is not yet available.

References

Araszkiewicz A, Bandurska-Stankiewicz E, Borys S, Budzyński A, Cyganek K, Cypryk K et al. 2022 Guidelines on the management of patients with diabetes. A position of Diabetes Poland. Current Topics in Diabetes. 2022;2(1):1-130. doi: 10.5114/ctd/146259.

Mao Y, Zhong W. Changes of insulin resistance status and development of complications in type 1 diabetes mellitus: Analysis of DCCT/EDIC study. Diabetes Res Clin Pract. 2022 Feb;184:109211. doi: 10.1016/j.diabres.2022.109211.

DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214-23. doi: 10.1152/ajpendo.1979.237.3.E214.

Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP. Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care. 2013 Aug;36(8):2280-5. doi: 10.2337/dc12-1693.

Šimonienė D, Platūkiene A, Prakapienė E, Radzevičienė L, Veličkiene D. Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data. Diabetes Ther. 2020 Jan;11(1):161-174. doi: 10.1007/s13300-019-00729-5.

Garofolo M, Gualdani E, Scarale MG, Bianchi C, Aragona M, Campi F, Lucchesi D, Daniele G, Miccoli R, Francesconi P, Del Prato S, Penno G. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care. 2020 Oct;43(10):e139-e141. doi: 10.2337/dc20-0433.

Avogaro A, Azzolina D, Fadini GP, Baldi I. Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studies. J Endocrinol Invest. 2021 Apr;44(4):745-753. doi: 10.1007/s40618-020-01368-5.

Katogiannis K, Vlastos D, Kousathana F, Thymis J, Kountouri A, Korakas E, Plotas P, Papadopoulos K, Ikonomidis I, Lambadiari V. Echocardiography, an Indispensable Tool for the Management of Diabetics, with or without Coronary Artery Disease, in Clinical Practice. Medicina (Kaunas). 2020 Dec 18;56(12):709. doi: 10.3390/medicina56120709.

Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018 Jan;61(1):21-28. doi: 10.1007/s00125-017-4390-4.

Liu JJ, Liu S, Ang KA, Lim SC. Estimated glucose disposal rate, a novel biomarker for insulin sensitivity, predicts risk for incident heart failure in patients with type 2 diabetes. European Heart Journal. 2023;44:ehac779.035. doi: 10.1093/eurheartj/ehac779.035.

Weber TR, da Silva RL, Cossul S, Alves MSL, Lee SVS, Marques JLB. The use of echocardiography in type 1 diabetes. Rev Port Cardiol (Engl Ed). 2021 Jul 19:S0870-2551(21)00249-3. English, Portuguese. doi: 10.1016/j.repc.2020.11.012.

Šuran D, Kanič V, Naji F, Krajnc I, Čokolič M, Zemljič E, Sinkovič A. Predictors of early cardiac changes in patients with type 1 diabetes mellitus: An echocardiography-based study. Bosn J Basic Med Sci. 2019 Jun 18;19(4):384-391. doi: 10.17305/bjbms.2019.4250.

Sawicka-Gutaj N. Publication ethics of human studies in the light of the Declaration of Helsinki – a mini-review. Journal of Medical Science. 2022;91(2):e700. doi: 10.20883/medical.e700.

Kulecki M, Naskret D, Kaminski M, Kasprzak D, Lachowski P, Klause D, Kozlowska M, Flotynska J, Uruska A, Zozulinska-Ziolkiewicz D. Association between central non-dipping pattern and platelet morphology in adults with type 1 diabetes without cardiovascular disease: a cross-sectional study. Sci Rep. 2021 Jul 29;11(1):15416. doi: 10.1038/s41598-021-94414-y.

Kulecki M, Naskret D, Kaminski M, Kasprzak D, Lachowski P, Klause D, Kozlowska M, Flotynska J, Uruska A, Zozulinska-Ziolkiewicz D. Arterial stiffness and the non-dipping pattern in type 1 diabetes males with and without erectile dysfunction. Sci Rep. 2023 May 4;13(1):7265. doi: 10.1038/s41598-023-33315-8.

Kamiński M, Kulecki M, Lachowski P, Kasprzak D, Kulczycka A, Kozłowska M, Klause D, Uruska A, Michalski M, Zozulińska-Ziółkiewicz D. Erectile Dysfunction in Individuals with Type 1 Diabetes is Associated with Long-term Metabolic Control and Diabetic Complications: A Cross-Sectional Study. Int J Angiol. 2022 Jan 13;31(2):97-106. doi: 10.1055/s-0041-1735209.

Galderisi M, Cosyns B, Edvardsen T, Cardim N, Delgado V, Di Salvo G, Donal E, Sade LE, Ernande L, Garbi M, Grapsa J, Hagendorff A, Kamp O, Magne J, Santoro C, Stefanidis A, Lancellotti P, Popescu B, Habib G; 2016–2018 EACVI Scientific Documents Committee; 2016–2018 EACVI Scientific Documents Committee. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1301-1310. doi: 10.1093/ehjci/jex244.

Lipiec P, Bąk J, Braksator W, Fijałkowski M, Gackowski A, Gąsior Z, Kasprzak JD, Klisiewicz A, Kowalski M, Kukulski T, Mizia-Stec K, Płońska-Gościniak E, Pruszczyk P, Sobkowicz B, Szymański P, Szyszka A, Trojnarska O, Wysokiński A, Hoffman P. Transthoracic echocardiography in adults — guidelines of the Working Group on Echocardiography of the Polish Cardiac Society [Transthoracic echocardiography in adults - guidelines of the Working Group on Echocardiography of the Polish Cardiac Society]. Kardiol Pol. 2018;76(2):488-493. Polish. doi: 10.5603/KP.2018.0051.

Guzik P, Więckowska B. Data distribution analysis – a preliminary approach to quantitative data in biomedical research. Journal of Medical Science. 2023;92:e869–e869. doi: 10.20883/medical.e869.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.

Pfaffenberger S, Bartko P, Graf A, Pernicka E, Babayev J, Lolic E, Bonderman D, Baumgartner H, Maurer G, Mascherbauer J. Size matters! Impact of age, sex, height, and weight on the normal heart size. Circ Cardiovasc Imaging. 2013 Nov;6(6):1073-9. doi: 10.1161/CIRCIMAGING.113.000690.

Zhu N, Chen H, Zhao X, Ye F, Jiang W, Wang Y. Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction. Medicine (Baltimore). 2019 Nov;98(48):e18146. doi: 10.1097/MD.0000000000018146.

Hirose K, Nakanishi K, Daimon M, Sawada N, Yoshida Y, Iwama K, Yamamoto Y, Ishiwata J, Hirokawa M, Koyama K, Nakao T, Morita H, Di Tullio MR, Homma S, Komuro I. Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community. Cardiovasc Diabetol. 2021 Jan 21;20(1):22. doi: 10.1186/s12933-020-01201-6.

Sakthivadivel V, Chinnathambi C, Selvaraju D, Gaur A, Bakthavatchalam R, Srivijayan A, Sundaramurthy R, Tadi LJ, John NA. Metabolic syndrome - cardiac structure and functional analysis by echocardiography; a cross sectional comparative study. Horm Mol Biol Clin Investig. 2023 Mar 2;44(3):305-310. doi: 10.1515/hmbci-2022-0066.

Left Ventricular Diameter and Risk Stratification for Sudden Cardiac Death – Journal of the American Heart Association. https://www.ahajournals.org/doi/10.1161/JAHA.114.001193. Accessed 15 Aug 2024.

Otowa-Suematsu N, Sakaguchi K, Kaneko A, Ito J, Morita Y, Miura H, Yamada T, So A, Komada H, Okada Y, Hirota Y, Tamori Y, Ogawa W. Relation of cardiac function to insulin resistance as evaluated by hyperinsulinemic-euglycemic clamp analysis in individuals with type 2 diabetes. J Diabetes Investig. 2021 Dec;12(12):2197-2202. doi: 10.1111/jdi.13608.

Echeverría LE, Saldarriaga C, Campbell-Quintero S, Morales-Rodríguez LN, López-Ponce de León JD, Buitrago AF, Martínez-Carreño E, Sandoval-Luna JA, Llamas A, Moreno-Silgado GA, Vanegas-Eljach J, Murillo-Benítez NE, Gómez-Paláu R, Rivera-Toquica AA, Gómez-Mesa JE, Research Group R. Diabetes mellitus in patients with heart failure and effect modification of risk factors for short-term mortality: An observational study from the Registro Colombiano de Falla Cardíaca (RECOLFACA). Biomedica. 2024 May 31;44(Sp. 1):182-197. doi: 10.7705/biomedica.6951.

Zhang J, Yang Z, Fan X, Fei Q, Xi Y. Positive Correlation between BMI and Left Ventricle and Atrium Inside Diameter Size in Chinese Type 2 Diabetes Patients with Left Ventricular and Atrial Enlargement. Rev Cardiovasc Med. 2024 Jun 4;25(6):207. doi: 10.31083/j.rcm2506207.

Khoury S, Zornitzki L, Laufer-Perl M, Bhatia RT, Marwaha S, Tome M, Granot Y, Gvili Perelman M, Avivi I, Shacham Y, Szekely Y, Banai S, Hochstadt A, Flint N, Topilsky Y. Sex-related differences in the association between septal wall thickness and survival. Int J Cardiol Heart Vasc. 2024 May 27;53:101427. doi: 10.1016/j.ijcha.2024.101427.

Fazio S, Mercurio V, Tibullo L, Fazio V, Affuso F. Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated. Front Cardiovasc Med. 2024 Mar 13;11:1380506. doi: 10.3389/fcvm.2024.1380506.

Abel ED. Insulin signaling in the heart. Am J Physiol Endocrinol Metab. 2021 Jul 1;321(1):E130-E145. doi: 10.1152/ajpendo.00158.2021.

Cai W, Sakaguchi M, Kleinridders A, Gonzalez-Del Pino G, Dreyfuss JM, O'Neill BT, Ramirez AK, Pan H, Winnay JN, Boucher J, Eck MJ, Kahn CR. Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression. Nat Commun. 2017 Mar 27;8:14892. doi: 10.1038/ncomms14892.

Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004 Mar;47(3):532-536. doi: 10.1007/s00125-004-1330-x.

Stout RW. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med. 1991 Feb 21;90(2A):62S-65S. doi: 10.1016/0002-9343(91)90041-u.

Paternostro G, Pagano D, Gnecchi-Ruscone T, Bonser RS, Camici PG. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res. 1999 Apr;42(1):246-53. doi: 10.1016/s0008-6363(98)00233-8.

Shi H, Chu H, Lv Z, Qi G, Guo J, Fu W, Wang X, Guo X, Ge J, Yin C. Association of white blood cell counts with left ventricular mass index in hypertensive patients undergoing anti-hypertensive drug therapy. Exp Ther Med. 2017 Apr;13(4):1566-1571. doi: 10.3892/etm.2017.4119.

Bajpai A, Tilley DG. The Role of Leukocytes in Diabetic Cardiomyopathy. Front Physiol. 2018 Nov 1;9:1547. doi: 10.3389/fphys.2018.01547.

Jensen MT, Sogaard P, Gustafsson I, Bech J, Hansen TF, Almdal T, Theilade S, Biering-Sørensen T, Jørgensen PG, Galatius S, Andersen HU, Rossing P. Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study. Diabetologia. 2019 Dec;62(12):2354-2364. doi: 10.1007/s00125-019-05009-2.

Lassen MCH, Biering-Sørensen T, Jørgensen PG, Andersen HU, Rossing P, Jensen MT. Sex differences in the association between myocardial function and prognosis in type 1 diabetes without known heart disease: the Thousand & 1 Study. Eur Heart J Cardiovasc Imaging. 2021 Aug 14;22(9):1017-1025. doi: 10.1093/ehjci/jeaa227.

Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet. 2011 Jul 9;378(9786):140-6. doi: 10.1016/S0140-6736(11)60471-6.

Hjortkjær HØ, Jensen T, Hilsted J, Mogensen UM, Corinth H, Rossing P, Sigvardsen PE, Fuchs A, Kühl JT, Nordestgaard BG, Køber L, Kofoed KF. Cardiac ventricular sizes are reduced in patients with long-term, normoalbuminuric type 1 diabetes compared to the non-diabetic background population. Diab Vasc Dis Res. 2019 May;16(3):289-296. doi: 10.1177/1479164118819961.

Wamil M, Coleman RL, Adler AI, McMurray JJV, Holman RR. Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89. Diabetes Care. 2021 Aug;44(8):1877-1884. doi: 10.2337/dc21-0429.

Dereziński T, Zozulińska‑Ziółkiewicz D, Uruska A, Dąbrowski M. Visceral adiposity index as a useful tool for the assessment of cardiometabolic disease risk in women aged 65 to 74. Diabetes Metab Res Rev. 2018 Nov;34(8):e3052. doi: 10.1002/dmrr.3052.

Downloads

Published

2024-12-31

Issue

Section

Original Papers

How to Cite

1.
Kulecki M, Naskręt D, Kamiński M, Kasprzak D, Lachowski P, Kulczycka A, et al. Cardiac dimensions, intraventricular septum thickness in relation to the estimated glucose disposal rate individuals with long-standing type 1 diabetes: a cross-sectional analysis of the PARADISE T1DM study. JMS [Internet]. 2024 Dec. 31 [cited 2025 Feb. 5];93(4):e1124. Available from: https://jms.ump.edu.pl/index.php/JMS/article/view/1124